FDA Investigator Megan A Haggerty

Megan A Haggerty has inspections in 11 countries as of 09 Nov 2023. Megan A Haggerty has collaborated with a combinined 7485 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
123
Last Inspection Date:
09 Nov 2023
Investigator Role:
FDA Investigator
Redica ID:
100007782
Country:
United States of America, France, Italy, Germany, Brazil, Belgium, Netherlands, United Kingdom of Great Britain and Northern Ireland, India, Poland
Co-Investigator(s):
A Williams, Abby E Pelletier, Abdu Alayash, Abdur Rafay Shareef, Aimee Cunningham, PhD, Aireen V Mendoza, Alan P Kurtzberg, Alan R Condon, Alice C Silva, Almaris N Alonso, Alois P Provost, Alysia M Salonia, Amber G Wardwell, Amy C Jordan, Amy Devlin, PhD, Amy N Chen, Andrew M Barlow, Angela E Glenn, Anissa M Cheung, Ann Marie Montemurro, Anne Carpenter, Anne E Carpenter, Anne Marie Dubrey, Anthony C Warchut, Anthony P Costello, Arie C Menachem, Arthur T Ogdahl, Ashley M Whitehurst, Barbara G Swan, Barbara I Rogolsky, Barbara J Rincon, Barbara Janine Breithaupt, Barbara L Rogolsky, Bo Chi, PhD, Bogdan Kurtyka, Bonita S Chester, Bradley D Newsad, Brenda P King, Brenda W Uratani, PhD, Brentley S Collins, Brently S Collins, Burnell M Henry, Byungja E Marciante, Calvin B Koerner, Camerson E Moore, Candace Y Gomez Broughton, Carla C Tuite, Carlos Chavez, Cassandra L Abellard, Catherine J Laufmann, Celia N Cruz, Charisse K Green, Charles Yuanchia Kuo, PhD, Charlotte Hinkle, Chelsea N Sealey, Cheryl A Clausen, Chiang Syin, PhD, Christian D Lynch (CDL), Christina Capacci Daniel, PhD, Christine E Kelley, Christine L Williams, Christopher A Demitrius, Christopher Downey, PhD, Christopher M Elliott, Christopher S Keating, Chryste Best, Chryste D Best, Constance Desimone, Courtney N Long, Craig T Rybus, Cynthia Jim, CSO, Cynthia Whitmarsh, Daniel L Zheng, Danielle S Pearson, Darin S Wiegers, Darla J Christopher, Daryl A Dewoskin, David P Vanhouten, David Van Houten, Dawn M Braswell, Deborah J Parris, Denise M Digiulio, Dennis Cantellops Paite, Devaugh Edwards, Devaughn Edwards, Diane C Thibodeau, Diane L Raccasi, Diane M Prince, Dien N Nguyen, Don H Bark, PhD, Donahue, Donald C Obenhuber, PhD, Dorothy W Lee, Douglas C Kovacs, Douglas Florentino, Dr. Carmelo Rosa, Dr. Robert C Horan, MD, Edmund F Mrak, Jr, Edmund Mrak, Edwin Melendez, Eileen A Liu, Ekaterina Allen, Elizabeth B Griffin, Elizabeth Ll Edwards, Ellen P Madigan, Eric M Mueller, PharmD, Erich P Garger, Erik W Koester, Erika E Englund, PhD, Felix Maldonado, Gary J Hagan, Gene D Arcy, George M Ibrahim, George T Allen, Jr, Gerald B Seaborn, Jr, Gerard D Difiore, Graeme E Price, Gunther Bockhoudt, Gunther Boekhoudt, PhD, Gwyn G Dickinson, Hala L Selby, Haley H Seymour, Harperd, Helen B Ricalde, Helen Verdel, Holly Brevig, Hugh M Mcclure, II, Irons, Ivis L Negron, Ivis Lnegron Torres, Jacek Cieslak, PhD, Jack Ragheb, Jacqueline Mdiaz Albertini, James C Maclaughlin, James Norman, James P Finn, James R Birkenstamm, Jamie S Mathews, Janete F Guardia, Jason A Rossi, Jawaid Hamid, Jay M Patria, Jayaleka J Amarasinghe, Jee Chung, PhD, Jeffrey J Thibodeau, Jennifer J Stone, Jennifer M Gogley, Jianming Li, Joan A Loreng, Jogy George, John A Sciacchitano, John D White, John J Thibodeau, John P Mistler, John P Shelton, John R Carlson, John S Hartford, Jonah S Ufferfilge, Jonathan B Lewis, Jonathan G Matrisciano, Joppie, Jorge L Guadalupe, Jose Acruz Gonzalez, Jose Alopez Rubet, Jose E Melendez, DDC, Jose O Hernandez, Jose Ohernandez Guzman, Jose R Hernandez, Joseph H Procopio, Joyce A Kellett, Joyce A Rockwell, Joyce A Williams, Julia D Bringger, Julianne C Mccullough, Julie A Finegan, Julie D Bringger, Jun Park, PhD, June P Page, Junho Pak, Justin A Boyd, Justine M Corson, Kalavati Suvarna, PhD, Kara A Scheibner, PhD, Karen A Briggs, Katherine D Adams, Kathleen E Mcafoose, Kathleen M Curry, Kathleen M Jordan, Kathleen R Jones, PhD, Katie L Korchinski, Kenneth H Williams, Kent A Conforti, Kevin A Gonzalez, Kristina J Donohue, L Norwood, Larry K Austin, Laura Fontan, MS, Laura L Staples, Lauren M Lawrance, Lauren N Barber, Laurie B Frazier, Laurie Graham, Laurie P Norwood, LCDR Debra Emerson, Lei Zhang, PhD, Leiyun Boone, PhD, Lewis K Antwi, Li Yun Huang, Lorayne A Mcguinness, Lori A Holmquist, Louis Christy, Luella J Rossi, Luis A Dasta, Lydia Irosas Marty, Lyndsay M Perryman, M Pedgen, Marcia M Laughrey, Margaret E Walsh, Margaret M Annes, Margaret M Sands, Margarita Santiago, Maria Joselopez Barragan, PhD, Marilyn Welchenbach, Marion Michaelis, Mariza M Jafary, Mark A Heard, Mark C Lookabaugh, Mark E Farrell, Mark R Mcclain, Marlene G Swider, Martha T Olone, Martin J Guardia, Mary E Storch, Mary Jeanet Mcgarry, Maryam Tabatabaie, Matthew C Watson, Matthew M Henciak, Maura Rooney, Maxwell Van Tassell, PhD, Maya M Davis, Megan A, Haggerty, Melissa J Garcia, Michael A Charles, Michael A Taylor, Michael E Maselli, Michael G Mayfield, Michael J Casey, Michael J Pasternak, Michael L Chasey, Michael P Anthony, Michael P Sheehan, Michael P Sweeney, Michael Shanks, MS, Michele L Forster, PhD, Michele L Obert, Michele Perry Williams, Michelle M Noe, Michelle Y Clark Stuart, Miguel A Martinez, Mihaly S Ligmond, Milan S Mcgorty, Milva E Melendez, Monica Commerford, PhD, Monique C Lo, Mra B Kamberem, Mra Munizn, Mutahar S Shamsi, Nabil Nakhoul, Nadeem I Chaudhry, Nailing Zhang, Nancy G Schmidt, Nancy T Waites, Nealie C Newberger, Nicholas A Violand, Nicholas L Paulin, Nichole B Murphy, Nicole E Knowlton, Nicole K Trudel, Nirjal Bhattarai, Obinna R Echeozo, Omotunde O Osunsanmi, Osama A Khatib, Pamela L Ogonowski, Pankaj H Amin, Paraluman S Leonin, Parul M Patel, Patricia A Homola, Patricia D Stahnke, Patricia Fhughes Troost, Patrick C Klotzbuecher, Paul E Stein, Paul L Bellamy, Paul P Geraci, Paula A Trost, Paula J Bretz, Paula Laplant, Paula M Laplant, Pei I Chu, Pete Amin (Pankaj), Philip F Istafanos, DMV, MS, Philip H Lafleur, Philip Kreiter, Phillip E Mclaughlin, Prabhu P Raju, Priscilla M Pastrana, Qing Joanna Zhou, PhD, Rachael O Oyewole, Rachel C Harrington, Raeann R Wu, Rajiv R Srivastava, Ralph H Vocque, Ramon E Martinez, Ranjani Prabhakara, Rashmi Rawat, PhD, Raymond T Oji, Rebecca A Coleman, Rebecca B Welch, Rebecca E Dombrowski, Rebecca Rodriguez, Reyes Candau Chacon, PhD, Richard A Abate, Richard F Hapke, Richard H Penta, Richard Ledwidge (nmi), PhD, Richard W Thornton, Robert D Tollefsen, Robert J Martin, Robert Mo Brien, Rodney G Raiford, Roger F Zabinski, Roman T Drews, PhD, Rory K Geyer, Rose M Ashley, Rozelle G Smith, Rupa Pradhan, Saleem A Akhtar, Samina S Khan, Sandra P White, Sara M Onyango, Sara M Richardson, Satheesh Thomas, Scott B Laufenberg, Scott C Lute, Scott Lute, Scott R Nichols, PhD, Scott T Ballard, Sean R Bryd, Sean R Marcsisin, Seth A Mailhot, Sharmista Chatterjee, Sharon K Thoma, PharmD, Shawn M Bogdan, Shirley S Wen, Simone E Pitts, Sina Shojaee, Sixto M Mercado Rios, Slater K Bartlett, Sneha S Patel, Sony Mathews, Stacey S Degarmo, State Agency, Stephen C King, Stephen C Smith, Stephen D Brown, Stephen J Koniers, Stephen R Souza, Steven C Madzo, Steven Fong, MS, PhD, Steven M Weinman, Sunita Pandey, Susan Krishner, Susan M Jackson, Susan Yu, Susanne M Richardson, MSc RAC ELS, Susant Hadman, Tamara S Rosbury, Tania K Mercado, Teddy Tom, Temar Q Williams, Teresa I Navas, Terri L Dodds, Theresa To, Theressa B Smith, Thomas E Friel, Thomas J Arista, Thomas W Nerney, Thuy T Nguyen, LCDR, Timothy M Glod, Timothy T Kapsala, Todd J Maushart, Towanda L Terrell, Valentino Fiorella, Vani Mathur Richards, Victor J Gangi, Victoria M Daddeo, Vioela J Caze, Virgilio F Pacio, CSO, Viviana Matta, Viviana R Ramirez, Vlada Matusovsky, Walter Lange, Wayne E Seifert, Wendy A Johnecheck, William Hallett, PhD, William J Leonard, Xiaokuang Lai, PhD, Yanming An, PhD, Yetao Jin, PhD, Ying Xin Fan, PhD, Yiping Jia, Yong Hu, Youmin Wang, Ze Peng, Zhihao Qiu (Peter), PhD, Zhong Li, PhD, Zhongren Wu, Ziyang Su, PhD

Megan A Haggerty's Documents

Publish Date Document Type Title
December, 2002 FDA 483 OPK Biotech, LLC - Form 483, 2002-11-22
May, 2014 FDA 483 AMAG Pharmaceuticals, Inc. - Form 483, 2014-05-21
April, 2003 EIR Stonyfield Farm - EIR, 2003-04-10
July, 2003 EIR Oraceutical LLC - EIR, 2003-07-08
March, 2013 EIR MERCK SERONO SPA - EIR, 2013-03-14
January, 2013 FDA 483 Isomedix Operations Inc - Form 483, 2013-01-04
February, 2011 FDA 483 Alexion Pharmaceuticals, Inc. - Form 483, 2011-02-18
November, 2008 EIR Antibioticos Do Brasil Ltda - EIR, 2008-11-06
February, 2013 FDA 483 Shire Human Genetic Therapies, Inc. - Form 483, 2013-02-26
October, 2008 FDA 483 Response Resilience US, Inc. - Form 483R, 2008-10-31
May, 2014 EIR AMAG Pharmaceuticals, Inc. - EIR, 2014-05-21
October, 2007 FDA 483 Lyne Laboratories, Inc. - Form 483, 2007-10-05
February, 2007 FDA 483 OPK Biotech, LLC - Form 483, 2007-02-01
April, 2008 FDA 483 Pharmalucence Inc. - Form 483, 2008-04-30
December, 2002 EIR OPK Biotech, LLC - EIR, 2002-12-18
October, 2008 FDA 483 AMAG Pharmaceuticals, Inc. - Form 483, 2008-10-22
March, 2007 EIR Curia Massachusetts, Inc. - EIR, 2007-03-30
March, 2013 FDA 483 SANUM-Kehlbeck GmbH & Co. KG - Form 483, 2013-03-26
September, 2012 FDA 483 Atrium Medical Corporation - Form 483, 2012-09-07
March, 2006 FDA 483 Lonza Biologics, Inc. - Form 483, 2006-03-24
September, 2003 FDA 483 Access CardioSystems - Form 483, 2003-09-24
August, 2012 FDA 483 Response Alexion Pharmaceuticals, Inc. - Form 483R, 2012-08-22
July, 2003 FDA 483 Response Oraceutical LLC - Form 483R, 2003-09-29
March, 2013 EIR SANUM-Kehlbeck GmbH & Co. KG - EIR, 2013-03-26
June, 2013 FDA 483 Bristol-Myers Squibb Company - Form 483, 2013-06-20
November, 2002 FDA 483 Professional Contract Sterilization, Inc. - Form 483, 2002-11-07
August, 2008 FDA 483 Biogen, Inc. - Form 483, 2008-08-22
November, 2007 FDA 483 Braintree Laboratories, Inc. - Form 483, 2007-11-20
March, 2003 FDA 483 Biopure Corporation - Form 483, 2003-03-27
October, 2008 FDA 483 Resilience US, Inc. - Form 483, 2008-10-10
October, 2010 FDA 483 Genzyme Corporation - Form 483, 2010-10-22
December, 2011 FDA 483 Citra Labs, LLC - Form 483, 2011-12-09
January, 2010 FDA 483 Braintree Laboratories, Inc. - Form 483, 2010-01-22
December, 2002 EIR OPK Biotech, LLC - EIR, 2002-11-14
December, 2002 FDA 483 OPK Biotech, LLC - Form 483, 2002-12-18
December, 2002 FDA 483 Response OPK Biotech, LLC - Form 483R, 2002-12-10
July, 2003 FDA 483 Oraceutical LLC - Form 483, 2003-07-08
October, 2008 FDA 483 Response AMAG Pharmaceuticals, Inc. - Form 483R, 2008-11-03
January, 2010 FDA 483 TGA Sciences, Inc. - Form 483, 2010-01-13
August, 2006 FDA 483 Citra Labs, LLC - Form 483, 2006-08-04
December, 2002 FDA 483 Response OPK Biotech, LLC - Form 483R, 2003-04-22
February, 2010 FDA 483 UL Verification Services - Form 483, 2010-02-01
March, 2014 FDA 483 The Dodge Company, Inc. - Form 483, 2014-03-25
November, 2008 FDA 483 Antibioticos Do Brasil Ltda - Form 483, 2008-11-06
April, 2010 FDA 483 Curia Massachusetts, Inc. - Form 483, 2010-04-01
August, 2012 FDA 483 Alexion Pharmaceuticals, Inc. - Form 483, 2012-08-06
September, 2010 EIR Biogen, Inc. - EIR, 2010-09-08
September, 2003 EIR Access CardioSystems - EIR, 2003-09-24

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more